期刊
INTERNATIONAL JOURNAL OF SURGERY
卷 23, 期 -, 页码 223-228出版社
ELSEVIER
DOI: 10.1016/j.ijsu.2015.07.724
关键词
Xenotransplantation; Antigen; Antibody; Non-Gal
类别
资金
- National Institute of Allergy and Infectious Disease at the National Institute of Health [AI066310]
- Comprehensive Biomedical Research Centre funds from the National Institute of Health Research
- National Institute for Health Research University College London Hospitals Biomedical Research Centre
- MRC [MR/L013193/1] Funding Source: UKRI
Genetic engineering of donor pigs to eliminate expression of the dominant xenogeneic antigen galactose alpha 1,3 galactose (Gal) has created a sea change in the immunobiology of xenograft rejection. Antibody mediated xenograft rejection of GGTA-1 alpha-galactosyltransferase (GTKO) deficient organs is now directed to a combination of non-Gal pig protein and carbohydrate antigens. Glycan analysis of GTKO tissues identified no new neo-antigens but detected high levels of N-acetylneuraminic acid (Neu5Gc) modified glycoproteins and glycolipids. Humans produce anti-Neu5Gc antibody and in very limited clinical studies sometimes show an induced anti-Neu5Gc antibody response after challenge with pig tissue. The pathogenicity of anti-Neu5Gc antibody in xenotransplantation is not clear however as non-human transplant models, critical for modelling anti-Gal immunity, do not produce anti-Neu5Gc antibody. Antibody induced after xenotransplantation in non-human primates is directed to an array of pig endothelial cells proteins and to a glycan produced by the pig B4GALNT2 gene. We anticipate that immune suppression will significantly affect the T-cell dependent and independent specificity of an induced antibody response and that donor pigs deficient in synthesis of multiple xenogeneic glycans will be important to future studies. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据